# Production/Formula Analysis — HPLC Data
# Date: 2026-09-07

## Found: HPLC Manufacturing Data

### Location
`innopharm-main-development` bucket (already downloaded)

### Files

| Type | Count | Content |
|------|-------|---------|
| HPLC_PDF_Output | 369 | Analysis PDFs |
| HPLC_TXT_Output | 501 | Raw chromatography data |

### Sample HPLC Analysis

**File:** `HPLC_PDF_Output__10_CO00001_C00003_FA250000001_26022301_100.pdf`

| Field | Value |
|-------|-------|
| Company | PHAROS |
| Machine | FA250000001-FACTORY QC |
| Analysis ID | 26022301 |
| Analysis Type | DISSOLUTION |
| Purpose | BATCH PRODUCTION |
| Batch Number | D6B631A |
| Product Name | **OZEN 10 MG** |
| Active Substance | **B4502842 - CETIRIZINE HCL** |
| Sample Origin | COATING |

### Data Content

| Column | Description |
|--------|-------------|
| Vial | Injection vial number |
| Injection Number | Injection sequence |
| Sample ID | Sample identifier |
| Area | Peak area (mAU·s) |
| Retention Time | Chromatography retention (min) |
| Tailing Factor | Peak shape |
| Peak Height | Peak amplitude |

### Manufacturing Process

| Step | Evidence |
|------|----------|
| Product | OZEN 10 MG (Cetirizine) |
| Batch | D6B631A |
| Process | COATING |
| QC | Dissolution testing |
| Standard | TE00002-1 |

## Analysis

**This is actual pharmaceutical manufacturing data:**
- HPLC chromatography analysis
- Batch production QC
- Active substance identification (Cetirizine HCL)
- Coating process validation

## Value

| Data | Value |
|------|-------|
| Product formulas | **HIGH** — actual drug composition |
| Manufacturing process | **HIGH** — QC/QA procedures |
| Batch records | **MEDIUM** — production history |
| HPLC methods | **MEDIUM** — analytical methods |

## Next Steps

1. **Extract all HPLC data** — 369 PDFs + 501 TXTs
2. **Map products** — product → batch → analysis
3. **Identify active substances** — API composition
4. **Negotiation** — leverage manufacturing data